https://www.mypharma-editions.com/gustave-roussy-et-takeda-annoncent-un-partenariat-scientifique-destine-a-faire-progresser-des-programmes-de-recherche-innovants-sur-les-tumeurs-solides-et-les-hemopathies-malignes 2026-11-05T10:56:34+00:00 hourly 1.0 https://www.mypharma-editions.com/myopathie-de-duchenne-premiers-resultats-intermediaires-encourageants-de-lessai-avance-1 2026-11-05T10:54:19+00:00 hourly 1.0 https://www.mypharma-editions.com/premier-patient-traite-dans-un-essai-de-phase-1-evaluant-bt-001-de-transgene-et-bioinvent-dans-le-cancer-du-rectum 2026-11-05T10:51:19+00:00 hourly 1.0 https://www.mypharma-editions.com/seabelife-soutenu-a-hauteur-de-29-millions-deuros-par-letat-afin-dobtenir-les-premieres-donnees-cliniques-de-son-candidat-medicament 2026-11-03T10:54:09+00:00 hourly 1.0 https://www.mypharma-editions.com/ispiron-veut-remettre-la-bioproduction-au-coeur-de-la-bataille-pour-la-souverainete-pharmaceutique-francaise 2026-11-03T10:47:22+00:00 hourly 1.0